Study Details

Healthy Adults, Age 18-65

Study Number

8409-184-2b

Group

Group 2

Gender

both

Age

18-65

Location

Madison, Wisconsin

Compensation

$7,658

Study Dates

Jan. 20 - May 26, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

•Healthy Non-Smoking Adults age 18-65

•BMI (body mass index) 18-30

•Join us for a stay of 8 nights followed by 11 outpatient visits

•Compensation up to $7658 may be provided for time and participation

Details

Screening Dates: Dec 31, Jan 3, 6, 7, 9, 10, 14, 15

Check-In: Jan 20
Check-Out: Jan 28

Outpatient Visits:
Jan 31
Feb 4, 11, 18
Mar 3, 17
Apr 14, 28
May 12, 26

Study Number

8409-184-2b

Group

Group 2

Gender

both

Age

18-65

Location

Madison, Wisconsin

Compensation

$7,658

Study Dates

Jan. 20 - May 26, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

•Healthy Non-Smoking Adults age 18-65

•BMI (body mass index) 18-30

•Join us for a stay of 8 nights followed by 11 outpatient visits

•Compensation up to $7658 may be provided for time and participation

Details

Screening Dates: Dec 31, Jan 3, 6, 7, 9, 10, 14, 15

Check-In: Jan 20
Check-Out: Jan 28

Outpatient Visits:
Jan 31
Feb 4, 11, 18
Mar 3, 17
Apr 14, 28
May 12, 26

Calculate Your BMI!

Calculate Your BMI!